Group 1 - The core viewpoint of the article highlights the recent stock performance of Xinyang (SY), which saw a 5.18% increase, reaching $5.08 per share, with a total market capitalization of $509 million as of August 9 [1] - Financial data indicates that as of March 31, 2025, Xinyang's total revenue amounted to 297 million RMB, reflecting a year-on-year decrease of 6.6%, while the net profit attributable to the parent company was -33.138 million RMB, a significant decline of 56.02% year-on-year [1] Group 2 - A major event reminder states that Xinyang is scheduled to disclose its fiscal year 2025 mid-term report on August 15, prior to the market opening in the Eastern Time Zone [2] - Xinyang International Company is dedicated to leveraging technology to assist women in enhancing their health and beauty, aiming to transform the opaque medical aesthetics market in China by providing transparent information and establishing a one-stop platform for quality services [2]